Industry Strength Score
17/100
Composite price performance score based on 3, 6, and 12-month returns, with more weight on recent trends.
CHARLES RIVER LABORATORIES (CRL) Stock Price & Overview
NYSE:CRL • US1598641074
Current stock price
163.84 USD
-2.95 (-1.77%)
At close:
163.84 USD
0 (0%)
After Hours:
The current stock price of CRL is 163.84 USD. Today CRL is down by -1.77%. In the past month the price decreased by -5.02%. In the past year, price increased by 38.31%.
CRL Key Statistics
52-Week Range113.885 - 228.88
Current CRL stock price positioned within its 52-week range.
1-Month Range161.53 - 190.14
Current CRL stock price positioned within its 1-month range.
- Market Cap
- 8.084B
- P/E
- 15.94
- Fwd P/E
- 14.71
- EPS (TTM)
- 10.28
- Dividend Yield
- N/A
CRL Stock Performance
Today
-1.77%
1 Week
-11.34%
1 Month
-5.02%
3 Months
-22.16%
Longer-term
6 Months -9.01%
1 Year +38.31%
2 Years -28.45%
3 Years -13.82%
5 Years -50.72%
10 Years +106.69%
CRL Stock Chart
CRL Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to CRL. When comparing the yearly performance of all stocks, CRL turns out to be only a medium performer in the overall market: it outperformed 56.96% of all stocks.
Chartmill TA Rating
Chartmill Setup Rating
CRL Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to CRL. CRL has only an average score on both its financial health and profitability.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
CRL Earnings
On February 18, 2026 CRL reported an EPS of 2.39 and a revenue of 994.23M. The company beat EPS expectations (0.98% surprise) and missed revenue expectations (-0.27% surprise).
Next Earnings DateMay 7, 2026
Last Earnings DateFeb 18, 2026
PeriodQ4 / 2025
EPS Reported$2.39
Revenue Reported994.227M
EPS Surprise 0.98%
Revenue Surprise -0.27%
CRL Forecast & Estimates
23 analysts have analysed CRL and the average price target is 206.55 USD. This implies a price increase of 26.07% is expected in the next year compared to the current price of 163.84.
For the next year, analysts expect an EPS growth of 8.35% and a revenue growth -1.8% for CRL
Analysts
Analysts78.26
Price Target206.55 (26.07%)
EPS Next Y8.35%
Revenue Next Year-1.8%
CRL Index Membership
CRL is currently included in the following stock indexes tracked on ChartMill.
CRL Financial Highlights
Over the last trailing twelve months CRL reported a non-GAAP Earnings per Share(EPS) of 10.28. The EPS decreased by -0.39% compared to the year before.
Income Statements
Revenue(TTM)4.02B
Net Income(TTM)-144.34M
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -2.02% | ||
| ROE | -4.56% | ||
| Debt/Equity | 0.68 |
Chartmill High Growth Momentum
EPS Q2Q%-10.15%
Sales Q2Q%-0.83%
EPS 1Y (TTM)-0.39%
Revenue 1Y (TTM)-0.85%
CRL Ownership
Ownership
Inst Owners110.65%
Shares49.34M
Float48.90M
Ins Owners0.84%
Short Float %9.54%
Short Ratio4.67
CRL Industry Overview
CRL operates in the Life Sciences Tools & Services sub-industry within the Health Care sector. This group contains 51 stocks and is scored by ChartMill on both price strength and growth momentum.
Industry Growth Score
53/100
Composite growth score based on earnings growth, revenue growth, and profitability across the sub-industry.
Relative Performance
Each rank shows how many other sub-industries were outperformed over that timeframe.
1 Month Rank
26%
Outperformed 26% of sub-industries
3 Month Rank
7%
Outperformed 7% of sub-industries
6 Month Rank
11%
Outperformed 11% of sub-industries
Industry Fundamentals & Breadth
- Members
- 51
- New Highs
- 0%
- New Lows
- 9.8%
- Average ROE
- 14.9%
- Average Profit Margin
- 15.8%
- Average Operating Margin
- 18.7%
- Average P/E
- 32.4
- Average Fwd P/E
- 28.1
- Average Debt/Equity
- 0.8
CRL Competitors/Peers
The largest stocks on the US markets in the "Life Sciences Tools & Services" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 17.21 | 174.743B | ||
| DHR | DANAHER CORP | 19.42 | 126.664B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 127.33 | 43.774B | ||
| A | AGILENT TECHNOLOGIES INC | 16.56 | 32.462B | ||
| WAT | WATERS CORP | 20.09 | 29.523B | ||
| IQV | IQVIA HOLDINGS INC | 12.21 | 26.688B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 26.41 | 25.565B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 32.86 | 21.057B | ||
| ILMN | ILLUMINA INC | 23 | 19.28B | ||
| MEDP | MEDPACE HOLDINGS INC | 21.37 | 11.7B | ||
| RVTY | REVVITY INC | 14.95 | 9.523B | ||
| TEM | TEMPUS AI INC-CL A | N/A | 9.167B | ||
| TECH | BIO-TECHNE CORP | 23.39 | 8.372B |
Related stock screener links
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About CRL
Company Profile
Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. The company is headquartered in Wilmington, Massachusetts and currently employs 18,300 full-time employees. The company went IPO on 2000-06-23. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. Its Research Models and Services segment includes three businesses that provide foundational tools that enable its clients to discover new molecules: Research Models, Research Model Services, and Cell Solutions. Its Discovery and Safety Assessment segment provides regulated and non-regulated DSA services to support the research, development, and regulatory-required safety testing of potential new drugs, including therapeutic discovery and optimization plus in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development. Its Manufacturing Solutions segment includes Microbial Solutions and Biologics Solutions.
Company Info
IPO: 2000-06-23
CHARLES RIVER LABORATORIES
251 Ballardvale St
Wilmington MASSACHUSETTS 01887 US
CEO: James C. Foster
Employees: 18300
Phone: 17812226000
CHARLES RIVER LABORATORIES / CRL FAQ
What does CRL do?
Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. The company is headquartered in Wilmington, Massachusetts and currently employs 18,300 full-time employees. The company went IPO on 2000-06-23. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. Its Research Models and Services segment includes three businesses that provide foundational tools that enable its clients to discover new molecules: Research Models, Research Model Services, and Cell Solutions. Its Discovery and Safety Assessment segment provides regulated and non-regulated DSA services to support the research, development, and regulatory-required safety testing of potential new drugs, including therapeutic discovery and optimization plus in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development. Its Manufacturing Solutions segment includes Microbial Solutions and Biologics Solutions.
What is the stock price of CHARLES RIVER LABORATORIES today?
The current stock price of CRL is 163.84 USD. The price decreased by -1.77% in the last trading session.
What is the dividend status of CHARLES RIVER LABORATORIES?
CRL does not pay a dividend.
What is the ChartMill rating of CHARLES RIVER LABORATORIES stock?
CRL has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
What is the analyst forecast for CRL stock?
23 analysts have analysed CRL and the average price target is 206.55 USD. This implies a price increase of 26.07% is expected in the next year compared to the current price of 163.84.
What is the employee count for CRL stock?
CHARLES RIVER LABORATORIES (CRL) currently has 18300 employees.
Who owns CHARLES RIVER LABORATORIES?
You can find the ownership structure of CHARLES RIVER LABORATORIES (CRL) on the Ownership tab.